What is the total value of India's pharmaceutical export to French Guiana?

India exported pharmaceuticals worth $269 to French Guiana across 1 verified shipments.

Who are the top Indian pharmaceutical exporters to French Guiana?

1. GLOBALSTAR COMPANY — $269. Total: 1 suppliers.

Which companies in French Guiana import pharmaceuticals from India?

1. JOHN-BAPTIST — $269. 1 buyers total.

What pharmaceutical products does India export most to French Guiana?

1. Pharmaceuticals Products Provironum Tabl ($269, 100.0%)

Which ports handle pharmaceutical shipments from India to French Guiana?

Export: SAHAR AIR CARGO ACC (INBOM4). Import: CAYENNE.

Why does French Guiana import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $269 corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply French Guiana?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to French Guiana pharmaceutical trade?

$269 per consignment across 1 shipments.

How many Indian pharmaceutical companies export to French Guiana?

1 Indian companies. Largest: GLOBALSTAR COMPANY with $269.

How can I find verified Indian pharmaceutical suppliers for French Guiana?

TransData Nexus covers 1 active exporters with shipment history and trade values at transdatanexus.com.

India to French Guiana Pharmaceutical Export (2026) — $269, 1 Suppliers | TransData Nexus

India to French Guiana Pharmaceutical Export (2026) — $269, 1 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to French Guiana

#	Formulation	Value	Share
1	Pharmaceuticals Products Provironum Tabl	$269	100.0%

India exports 1+ pharmaceutical formulations to French Guiana with a combined trade value of $269.. These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1 verified Indian Customs (DGFT) shipment records.

Top Indian Exporters to French Guiana

1Globalstar Company

$269

1 Indian pharmaceutical companies export finished formulations to French Guiana. Leading exporters include Globalstar Company, . The top exporter accounts for 100.0% of total India–French Guiana pharma exports. Source: Indian Customs (DGFT).

Top French Guiana Buyers from India

1John-baptist

$269

1 companies in French Guiana import pharmaceutical formulations from India. Top buyers include John-baptist, . The largest buyer accounts for 100.0% of India–French Guiana pharma imports. Source: Indian Customs (DGFT).

Port Analysis — India to French Guiana Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR CARGO ACC (INBOM4)100.0%

French Guiana Import Ports

CAYENNE100.0%

Trade Statistics

Total Value$269

Shipments1

Indian Exporters1

French Guiana Buyers1

Avg Shipment$269

Products1

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–French Guiana Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade between India and French Guiana has been minimal, with a total export value of $269 USD from India to French Guiana over the period from 2022 to 2026. This figure is based on a single shipment of Provironum Tablets, a finished pharmaceutical formulation, exported by Globalstar Company to John-Baptist in French Guiana. The shipment was routed through Sahar Air Cargo Complex in India to Cayenne, the primary import port in French Guiana. This limited trade volume suggests that the pharmaceutical corridor between India and French Guiana is underdeveloped, with significant potential for growth.

2India's Market Position

Given the negligible trade volume, India's share in French Guiana's pharmaceutical imports is currently minimal. The strategic importance of this market lies in French Guiana's status as an overseas region of France, subject to European Union regulations. This alignment offers Indian pharmaceutical exporters a unique opportunity to access the EU market through French Guiana, potentially serving as a gateway for broader European distribution.

3Recent Developments

French Guiana Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in French Guiana must comply with the European Medicines Agency (EMA) guidelines, as French Guiana adheres to EU pharmaceutical regulations. The registration process involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) format, which includes detailed information on the product's quality, safety, and efficacy. Bioequivalence studies may be required, especially for generic formulations, to demonstrate therapeutic equivalence to the reference product. The timeline for registration can vary, but it generally takes several months to complete the evaluation and approval process.

2GMP & Facility Requirements

French Guiana requires that manufacturing sites adhere to Good Manufacturing Practice (GMP) standards recognized by the EMA. Indian manufacturers must ensure their facilities comply with these standards to gain approval for exporting to French Guiana. The inspection process involves a thorough assessment of the manufacturing facility's processes, quality control measures, and documentation. While there is no explicit mutual recognition agreement between India and the EU, compliance with EMA-recognized GMP standards facilitates smoother market entry.

3Import Documentation

Importing pharmaceutical products into French Guiana requires specific documentation, including an import license, Certificate of Pharmaceutical Product (CPP), Certificate of Analysis (CoA), and proof of GMP compliance. Customs procedures involve clearance at the Cayenne port, where the documentation is reviewed to ensure compliance with French and EU regulations. Given French Guiana's status as an overseas region of France, import procedures align with those of mainland France, necessitating adherence to EU customs protocols.

TransData Nexus Research · French Guiana regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to French Guiana identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1 verified shipments from 1 Indian exporters to 1 French Guiana buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1 Exporters

1 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to French Guiana Pharmaceutical Export

Top Pharmaceutical Formulations — India to French Guiana

Top Indian Exporters to French Guiana

Top French Guiana Buyers from India

Port Analysis — India to French Guiana Pharmaceutical Shipments

Indian Export Ports

French Guiana Import Ports

Trade Statistics

Other Destinations

India–French Guiana Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Full Dataset Access

French Guiana Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to French Guiana

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and French Guiana

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to French Guiana Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — French Guiana for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to French Guiana

1Competing Origins

2India's Competitive Edge

3Challenges & Threats

FAQ — India to French Guiana Pharmaceutical Trade